Compound ML302
(Z)-N-(4-Methylpiperazin-1-yl)-2-(4-oxo-2-thioxo-5-(2,3,6-trichlorobenzylidene)thiazolidin-3-yl)acetamide
From: Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition
View in PubChem | MDL Molfile | ChemDraw
InChIKey GTHJLNHVDYJCCB-JYRVWZFOSA-N
Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.
ML302 was prepared according to a literature procedure (Spicer, T. et al. ML302: A Novel Beta-lactamase (BLA) Inhibitor. in Probe Reports from the NIH Molecular Libraries Program (National Center for Biotechnology Information (US), Bethesda (MD), 2010))
